GlassScriptPhysician profile
Cheryl Sadler
NPI 1568988277
$1,307.88
in general payments reported to CMS, 2019-2025
17 companies · $172 in 2025
The $172 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $238 · 2022: $173 · 2023: $416 · 2024: $310 · 2025: $172.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $897.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $896.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Galderma Laboratories, L.P. | $339.81 | 2021-2025 | Dysport |
| Collegium Pharmaceutical, INC. | $316.82 | 2021-2025 | Xtampza, Belbuca |
| Indivior INC. | $121.86 | 2024-2025 | Sublocade |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $85.46 | 2021-2022 | |
| Braeburn INC. | $82.26 | 2023-2024 | Brixadi |
| Nevro Corp. | $72.41 | 2021-2024 | Senza |
| Si-Bone, INC. | $35.45 | 2021 | |
| Vertex Pharmaceuticals Incorporated | $33.99 | 2024 | |
| Abbvie INC. | $33.06 | 2021-2022 | |
| Boston Scientific Corporation | $31.98 | 2023 | |
| Ethicon US, LLC | $27.79 | 2023 | Enseal |
| Kowa Pharmaceuticals America, INC. | $24.22 | 2023 | Seglentis |
| Grt US Holding, INC. | $22.91 | 2021 | |
| Redhill Biopharma INC. | $22.27 | 2022 | |
| Hikma Pharmaceuticals USA | $21.27 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bioventus LLC | $20.58 | 2021 | |
| Averitas Pharma INC. | $15.74 | 2023 | Qutenza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cheryl Sadler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.